We are live on
!
Find out more
AA
AlphaCentric Advisors Portfolio holdings
AUM
$118M
This Fund
S&P 500
This Quarter
Est. Return
+7.21%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$166M
AUM Growth
+$16.8M
(+11%)
Cap. Flow
+$19.2M
Cap. Flow
% of AUM
11.58%
Top 10 Holdings %
Top 10 Hldgs %
22.19%
Holding
254
New
38
Increased
43
Reduced
118
Closed
26
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
United Therapeutics
UTHR
|
+$3.61M |
| 2 |
NARI
Inari Medical, Inc. Common Stock
NARI
|
+$3.1M |
| 3 |
Axsome Therapeutics
AXSM
|
+$2.73M |
| 4 |
Pfizer
PFE
|
+$2.64M |
| 5 |
TRML
Tourmaline Bio
TRML
|
+$2.15M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
IMGN
Immunogen Inc
IMGN
|
+$3.78M |
| 2 |
WBA
Walgreens Boots Alliance
WBA
|
+$3.13M |
| 3 |
ABVX
Abivax
ABVX
|
+$2.86M |
| 4 |
Ironwood Pharmaceuticals
IRWD
|
+$2.8M |
| 5 |
Amylyx Pharmaceuticals
AMLX
|
+$2.22M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 61.45% |
| 2 | Real Estate | 11.2% |
| 3 | Financials | 4.6% |
| 4 | Industrials | 3.92% |
| 5 | Technology | 2.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
iShares MSCI South Korea ETF
EWY
$21.7B
| $130K | 0.08% |
1,930
+144
| +8% | +$9.14K |
|
152
iShares MSCI Poland ETF
EPOL
$669M
| $125K | 0.08% |
5,309
-419
| -7% | -$9.43K |
|
153
iShares MSCI India ETF
INDA
$6.71B
| $125K | 0.08% |
2,419
-286
| -11% | -$14.4K |
|
154
iShares MSCI Philippines ETF
EPHE
$127M
| $125K | 0.08% |
+4,507
| New | +$122K |
|
155
iShares MSCI Malaysia ETF
EWM
$305M
| $124K | 0.07% |
+5,695
| New | +$122K |
|
|
GREK
156
Global X MSCI Greece ETF
GREK
$288M
| $123K | 0.07% |
3,085
-243
| -7% | -$9.62K |
|
157
Microbot Medical
MBOT
$115M
| $123K | 0.07% |
100,000
| – | – |
|
158
iShares MSCI Brazil ETF
EWZ
$9.05B
| $122K | 0.07% |
3,749
+89
| +2% | +$2.94K |
|
159
iShares MSCI Spain ETF
EWP
$1.98B
| $121K | 0.07% |
3,759
+134
| +4% | +$4.03K |
|
160
Cigna
CI
$76.6B
| $119K | 0.07% |
328
-45
| -12% | -$14.8K |
|
161
iShares MSCI Turkey ETF
TUR
$206M
| $119K | 0.07% |
3,301
+1,453
| +79% | +$51.9K |
|
162
iShares MSCI Italy ETF
EWI
$911M
| $116K | 0.07% |
3,087
-268
| -8% | -$9.38K |
|
163
Mercado Libre
MELI
$91.3B
| $116K | 0.07% |
77
-11
| -13% | -$18K |
|
164
iShares MSCI Austria ETF
EWO
$146M
| $116K | 0.07% |
5,328
+97
| +2% | +$2.04K |
|
165
General Motors
GM
$74.7B
| $115K | 0.07% |
2,534
-338
| -12% | -$13.1K |
|
166
iShares MSCI United Kingdom ETF
EWU
$4.04B
| $115K | 0.07% |
3,359
-57
| -2% | -$1.87K |
|
167
DaVita
DVA
$15.1B
| $114K | 0.07% |
828
-114
| -12% | -$13.7K |
|
168
iShares MSCI Netherlands ETF
EWN
$562M
| $114K | 0.07% |
2,304
-319
| -12% | -$14.9K |
|
169
iShares MSCI Germany ETF
EWG
$1.5B
| $114K | 0.07% |
3,590
-304
| -8% | -$9.11K |
|
170
Vertiv
VRT
$112B
| $114K | 0.07% |
1,393
-188
| -12% | -$11.8K |
|
171
iShares MSCI France ETF
EWQ
$324M
| $113K | 0.07% |
2,736
-209
| -7% | -$8.26K |
|
172
Wells Fargo
WFC
$261B
| $113K | 0.07% |
1,946
-252
| -11% | -$13.2K |
|
173
iShares MSCI Switzerland ETF
EWL
$2.12B
| $112K | 0.07% |
2,350
-86
| -4% | -$4.08K |
|
174
iShares MSCI Sweden ETF
EWD
$522M
| $111K | 0.07% |
2,782
-290
| -9% | -$11.2K |
|
175
McKesson
MCK
$98.5B
| $110K | 0.07% |
205
-28
| -12% | -$14.2K |
|
Similar funds
AIS
IVGAI
OIM
TIP
RCG
CWM
SPW
WLC
AlphaCentric Advisors's Q1 2024 Portfolio in Review
As of Q1 2024, AlphaCentric Advisors held 254 positions worth $166M, up 11% from $149M the previous quarter. Its ten largest holdings account for 22% of the portfolio.
AlphaCentric Advisors deployed $19.2M of net new capital in Q1 2024, opening 38 new positions and adding to 43 existing holdings. Its largest new stake was United Therapeutics: 16,000 shares worth $3.68M.
By sector, the portfolio is most concentrated in Healthcare at 61% of assets, up from 59% a quarter earlier, followed by Real Estate and Financials.
On the sell side, the largest reduction was Invesco NASDAQ 100 ETF, an estimated $1.72M trimmed.
- AlphaCentric Advisors's largest Q1 2024 buy was United Therapeutics: 16,000 shares worth $3.68M.
- AlphaCentric Advisors added most to Inari Medical, Inc. Common Stock in Q1 2024, an estimated $3.1M increase.
- AlphaCentric Advisors's biggest Q1 2024 reduction was Invesco NASDAQ 100 ETF, cutting an estimated $1.72M.
- AlphaCentric Advisors fully exited Immunogen Inc in Q1 2024, selling an estimated $3.78M.
- AlphaCentric Advisors's ten largest holdings make up 22% of its $166M portfolio in Q1 2024.
- AlphaCentric Advisors opened 38 new positions and closed 26 in Q1 2024.
- AlphaCentric Advisors's portfolio value rose 11% quarter-over-quarter to $166M.
Based on AlphaCentric Advisors's 13F filing for Q1 2024, filed 24 Apr 2024.